New approach for early diagnosis in patients with Turner-Syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022565

Enrollment

Registered

2020-08-07

Start date

2020-08-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q96

Interventions

Group 1: Turner-Syndrome is a genotypic and phenotypic highly variable disease. Late diagnosis is still a problem and affected women lose preventive and therapeutic opportunities. The only sceening to

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with already diagnosed Turner-Syndrome

Exclusion criteria

Exclusion criteria: Patients without Turner-Syndrome

Design outcomes

Primary

Measure	Time frame
Detactability of Turner-Syndrome and ist genetic variants with different moleculargenetic methods.	—

Secondary

Measure	Time frame
Cost effectiveness of different genetic testing methods in the light of their use as Screening tools.	—

Countries

Germany

Contacts

Public ContactIvonne Bedei

Universität Giessen und Marburg

ivonne.bedei@gyn.med.uni-giessen.de064198559109

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026